Veltio Pharma AB

ABActive

Org 5591612840UppsalaResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2018 · 8 years old1-4 employees

Overview Financials People & ownership Related companies

Veltio Pharma AB is a Swedish AB based in Uppsala, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2018, the company reported revenue of SEK 282K in its latest annual filing.

Revenue 2025

SEK 282K

+262% vs 2024

EBITDA margin

-1742.3%

-84% vs 2024

Net profit 2025

SEK -5,2M

-76% vs 2024

Key ratios

See full ratios →

87.3%

This company

20212025

6.5×

This company

20212025

-90.4%

This company

20212025

EBITDA — year on year

SEK millions

Key figures

Annual report 2025

Revenue	SEK 282K	+262%
EBITDA	SEK -4,9M	-84%
Net profit	SEK -5,2M	-76%
Total assets	SEK 5,7M	+149%
Equity	SEK 5M	+188%
Employees	—	—

Contact

Address

Uppsala

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Veltio Pharma AB?

Veltio Pharma AB is registered with Bolagsverket / SCB under Org 5591612840.

What is the revenue of Veltio Pharma AB?

Veltio Pharma AB reported revenue of SEK 282K in 2025.

Who is the CEO of Veltio Pharma AB?

Lisa Stina Katarina Lundgren is the CEO of Veltio Pharma AB, in role since 2025.

Who is the chairman of Veltio Pharma AB?

Jon Daniel Bergström chairs the board of Veltio Pharma AB, in role since 2022.

Where is Veltio Pharma AB headquartered?

Veltio Pharma AB's registered address is Uppsala.

Veltio Pharma AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Veltio Pharma AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Veltio Pharma AB